The Lessines site prepares, purifies and packages immunoglobulin concentrates (IGIV) in liquid and freeze-dried form for intravenous injection.
Apart from these activities, BioScience Lessines analyses and packages finished products on site and medicines from other BioScience units such as recombinant products from genetic engineering recommended in the treatment of haemophilia. All these products are then distributed all over the world.
Print this page
